---
title: "China Health Group Raises HK$25.27 Million Through New Share Subscription"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/277090022.md"
description: "China Health Group Limited has raised HK$25.27 million through a share subscription, issuing 48 million new shares at HK$0.53 each, increasing its share capital by approximately 3.6%. The new shares will slightly dilute existing holdings but will enhance liquidity and support ongoing operations. About 40% of the proceeds will be used for future investments, while 60% will cover general working capital. The stock currently holds a Hold rating with a price target of HK$0.58."
datetime: "2026-02-26T14:09:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277090022.md)
  - [en](https://longbridge.com/en/news/277090022.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277090022.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/277090022.md) | [English](https://longbridge.com/en/news/277090022.md)


# China Health Group Raises HK$25.27 Million Through New Share Subscription

### Claim 50% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

The latest announcement is out from China Health Group ( (HK:0673) ).

China Health Group Limited has completed a share subscription, issuing 48 million new shares at HK$0.53 each under a general mandate, expanding its share capital by about 3.6 percent. The new shares represent roughly 3.46 percent of the enlarged capital base, slightly diluting existing holdings of major shareholders and public investors while introducing a new subscriber.

The transaction will raise net proceeds of about HK$25.27 million, with around 40 percent earmarked for future investments and the remaining 60 percent allocated to general working capital, including staff costs, rent, and supplier payments. The capital injection is expected to strengthen the group’s liquidity position and support ongoing operations and potential investment opportunities, with controlling shareholders retaining majority control despite marginal dilution.

The most recent analyst rating on (HK:0673) stock is a Hold with a HK$0.58 price target. To see the full list of analyst forecasts on China Health Group stock, see the HK:0673 Stock Forecast page.

**More about China Health Group**

China Health Group Limited, listed in Hong Kong, operates in the healthcare sector and conducts its business under the name CHG HS Limited. The company focuses on health-related services and investments, using the capital markets to support its operational funding needs and future expansion in its core medical and health businesses.

**Average Trading Volume:** 402,649

**Technical Sentiment Signal:** Hold

**Current Market Cap:** HK$843.7M

### 相關股票

- [CHINA HEALTH (00673.HK)](https://longbridge.com/zh-HK/quote/00673.HK.md)

## 相關資訊與研究

- [China Health Group kündigt Ausgabe von 48 Millionen neuen Aktien an](https://longbridge.com/zh-HK/news/274530078.md)
- [CloudCoCo Chair Lifts Stake to Over 21% in Vote of Confidence](https://longbridge.com/zh-HK/news/281552205.md)
- [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/zh-HK/news/281325910.md)
- [Osl Group FY adjusted non-IFRS income HK$534.1 million](https://longbridge.com/zh-HK/news/281223382.md)
- [CICC Sticks to Its Buy Rating for CIMC Enric Holdings (CIMEF)](https://longbridge.com/zh-HK/news/281132485.md)